MedTrace Logo

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage

NCT05159219 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-01-16

No results posted yet for this study

Summary

The overall goal is to establish the safety and efficacy of colchicine in ICH patients for the prevention of major cardiovascular events and brain injury. Colchicine for the prevention of vascular events after an acute intracerebral hemorrhage (CoVasc-ICH) is a vanguard pilot trial designed to obtain the factual feasibility prerequisites essential for the planning, design, funding and execution of a subsequent phase III trial.

Conditions

  • Intracranial Hemorrhages

Interventions

DRUG

Colchicine Pill

Anti-inflammatory

OTHER

Placebo

Inert ingredients

Sponsors & Collaborators

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Aristeidis Katsanos, MD · Population Health Research Institute

  • Ashkan Shoamanesh, MD · Population Health Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-04
Primary Completion
2024-12-03
Completion
2024-12-03

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05159219 on ClinicalTrials.gov